Skip to main content
Livermore
Livermore
ZHEN

Commonwealth Equity Services, LLC

SEC CIK
0000312272
Latest filing
Jul 29, 2026

SGMOQ holding history

Sangamo Therapeutics, Inc in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SGMOQ overviewAll 13F holders of SGMOQFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of SGMOQ by Commonwealth Equity Services, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−157,811−100.0%Sold outHolders
Q1 2026157,811$39.0K<0.1%00.0%UnchangedHolders
Q4 2025157,811$66.3K<0.1%+21,487+15.8%AddedHolders
Q3 2025136,324$92.0K<0.1%−11,990−8.1%ReducedHolders
Q2 2025148,314$80.0K<0.1%+50,000+50.9%AddedHolders
Q1 202598,314$64.0K<0.1%+2,813+2.9%AddedHolders
Q4 202495,501$97.0K<0.1%+27,353+40.1%AddedHolders
Q3 202468,148$59.0K<0.1%+8,400+14.1%AddedHolders
Q2 202459,748$21.0K<0.1%−204−0.3%ReducedHolders
Q1 202459,952$40.0K<0.1%+28,304+89.4%AddedHolders
Q4 202331,648$17.0K<0.1%−18,648−37.1%ReducedHolders
Q3 202350,296$30.0K<0.1%+4,436+9.7%AddedHolders
Q2 202345,860$60.0K<0.1%+18,895+70.1%AddedHolders
Q1 202326,965$47.0K<0.1%+387+1.5%AddedHolders
Q4 202226,578$83.0K<0.1%+2,754+11.6%AddedHolders
Q3 202223,824$116.0K<0.1%00.0%UnchangedHolders
Q2 202223,824$98.0K<0.1%+818+3.6%AddedHolders
Q1 202223,006$133.0K<0.1%−8,814−27.7%ReducedHolders
Q4 202131,820$238.0K<0.1%−1,218−3.7%ReducedHolders
Q3 202133,038$297.0K<0.1%−2,391−6.7%ReducedHolders
Q2 202135,429$424.0K<0.1%−1,100−3.0%ReducedHolders
Q1 202136,529$457.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.